C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2006
12/21/2006	WO2006083673A3 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases
12/21/2006	WO2006069159A3 Pharmaceutical compositions comprising amorphous benzimidazole compounds
12/21/2006	WO2006057921A3 Piperidinyl piperidine tachykinin receptor antagonists
12/21/2006	WO2006055922A3 Anthranilamide insecticides
12/21/2006	WO2006034235A3 Substituted quinoline and quinazoline inhibitors of quinone reductase 2
12/21/2006	WO2006012237A3 Aripiprazole crystaline forms and associated methods
12/21/2006	WO2005118538A3 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/21/2006	WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
12/21/2006	WO2005092856A8 Tetrahydrocarbazoles and derivatives
12/21/2006	WO2005072376A3 Anionic-sweetener-based ionic liquids and methods of use thereof
12/21/2006	WO2005047244A3 Inhibition of fgfr3 and treatment of multiple myeloma
12/21/2006	WO2005032468A3 Monocyclic and bicyclic lactams as factor xa inhibitors
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287378 Novel pyrroles and imidazoles
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287376 2-bromoaniline and 2-chloroaniline derivatives; used to make indole compounds
12/21/2006	US20060287370 Isoindolinone kinase inhibitors
12/21/2006	US20060287369 Diarylmethyl and related compounds
12/21/2006	US20060287363 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists
12/21/2006	US20060287351 Antibiotic cycloalkyltetrahydroquinoline derivatives
12/21/2006	US20060287349 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency
12/21/2006	US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders
12/21/2006	US20060287339 Aza- and polyazanthranyl amides and their use as medicaments
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators
12/21/2006	US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006	US20060287295 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/21/2006	US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction
12/21/2006	US20060287290 Azabicyclic compounds are central nervous system active agents
12/21/2006	DE19916460B4 Substituierte Benzimidazole, deren Herstellung und Anwendung Substituted benzimidazoles, their preparation and application
12/21/2006	CA2611979A1 Substituted arylpyrazoles
12/21/2006	CA2611917A1 Injection
12/21/2006	CA2611892A1 Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents
12/21/2006	CA2611711A1 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
12/21/2006	CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	CA2611495A1 Aminopyrimidines as kinase modulators
12/21/2006	CA2611470A1 Aminopyrimidines as kinase modulators
12/21/2006	CA2611378A1 Aminoquinoline and aminoquinazoline kinase modulators
12/21/2006	CA2611242A1 Alkylquinoline and alkylquinazoline kinase modulators
12/21/2006	CA2611219A1 Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis
12/21/2006	CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006	CA2610588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/21/2006	CA2610429A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives
12/21/2006	CA2610428A1 Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
12/21/2006	CA2610193A1 Methods and intermediates for the preparation of optionally radio-labeled imatinib
12/21/2006	CA2610105A1 Process for the synthesis of organic compounds
12/20/2006	EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006	EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative
12/20/2006	EP1734038A1 Nitrogenous heterocycle derivative and organic electroluminescent element employing the same
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1732928A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
12/20/2006	EP1732918A1 Novel pyrrolidine-3,4-dicarboxamide derivatives
12/20/2006	EP1732917A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
12/20/2006	EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/20/2006	EP1732901A1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
12/20/2006	EP1732898A1 Tetrahydroisoquinoline- and tetrahydrobenzazepine derivatives as igf-1r inhibitors
12/20/2006	EP1732897A1 Quinolone carboxylic acid derivatives for treatment of hyperproliferative conditions
12/20/2006	EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
12/20/2006	EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
12/20/2006	EP1732892A1 Tetrahydrocarbazoles and derivatives
12/20/2006	EP1732865A1 Fluoridation method
12/20/2006	EP1732566A2 6-azaindole compound
12/20/2006	EP1732564A1 Biaryl substituted pyrazinones as sodium channel blockers
12/20/2006	EP1732562A2 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
12/20/2006	EP1732560A1 Substituted cinnolin-4-ylamines
12/20/2006	EP1732552A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
12/20/2006	EP1732385A1 Use of (3-(1-(3-phenyl-propenyl)-piperidin-4-yl)-2,3-dihydro-indol-1-yl)-(pyridin-4-yl)-methanone derivatives and related compounds as insecticides
12/20/2006	EP1651220B1 2-[4- (2-hydroxymethyl-phenylamino)-piperidin-1-yl] - n-(9h-carbazol-3-yl) - acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
12/20/2006	EP1648458B1 2-[4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamide derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity
12/20/2006	EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	EP1276720B1 2-acyl indol derivatives and their use as anti-tumour agents
12/20/2006	EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/20/2006	EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006	EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
12/20/2006	EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
12/20/2006	EP0794946B1 Alkylidenehydrazinophenylsulphonyl ureas, methods of preparing them and their use as herbicides and plant-growth regulators
12/20/2006	CN1882581A Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
12/20/2006	CN1882580A Quinazoline derivatives as antiproliferative agents
12/20/2006	CN1882577A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882573A Quinazoline derivatives as tyrosine kinase inhibitors
12/20/2006	CN1882572A Quinazoline derivatives as antitumor agents
12/20/2006	CN1882571A Pyrrolderivate
12/20/2006	CN1882570A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882569A 喹唑啉衍生物 Quinazoline derivatives
12/20/2006	CN1882568A Pyrrol derivatives with antibacterial activity
12/20/2006	CN1882567A Quinazoline derivatives as tyrosine kinase inhibitors
12/20/2006	CN1882566A Crystalline forms of (+)- and (-)-erythro-mefloquine hydrochloride
12/20/2006	CN1882565A Novel piperidine-substituted indoles-or hetero-derivatives thereof and their use as modulators of chemokine receptor (CCR-3)
12/20/2006	CN1882564A Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
12/20/2006	CN1882560A Heterocompound and its production and usage method
12/20/2006	CN1882551A Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1882549A 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882545A Substituted nicotinoylcarbamates as pesticides
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1882540A Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics
12/20/2006	CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors
12/20/2006	CN1882347A AKT protein kinase inhibitors

1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 1080